Archives: Contractor Email

Dear Contractor

Please see correspondence below from Joe Brogan, Assistant Director of Integrated Care, Head of Pharmacy and Medicines Management.

Letter

Appendix I Template

SUMMARY

Accord-UK Ltd has announced that all strengths of their branded modified release gliclazide tablets, Bilxona® have been discontinued. This is a commercial decision made by the pharmaceutical company.

ACTION REQUIRED

The discontinuation of this brand will require prescriptions for Bilxona® to be changed to gliclazide MR.                                                                         Identify patients currently being prescribed Bilxona® in order for their prescriptions to be changed. A template letter for patients to support the prescribing changes is included within the correspondence.

If you require further information, please contact your local HSCB Pharmacy Adviser.

Yours sincerely

Vanessa

SENT ON BEHALF OF DR. VANESSA CHAMBERS | Head of Policy & Development

Dear Contractor

Please see correspondence below from Joe Brogan, Assistant Director of Integrated Care, Head of Pharmacy and Medicines Management.

SUMMARY

Accord-UK Ltd has announced that all strengths of their branded modified release gliclazide tablets, Bilxona® have been discontinued. This is a commercial decision made by the pharmaceutical company.

ACTION REQUIRED

  • The discontinuation of this brand will require prescriptions for Bilxona® to be changed to Gliclazide MR.                                                                        
  • Identify patients currently being prescribed Bilxona® in order for their prescriptions to be changed. A template letter for patients to support the prescribing changes is included within the correspondence.

If you require further information, please contact your local HSCB Pharmacy Adviser.

Yours sincerely

Vanessa

SENT ON BEHALF OF DR. VANESSA CHAMBERS | Head of Policy & Development

Dear Contractor

The Department of Health has written to contractors clarifying the position in respect of prescriptions issued by EEA Health Professionals following the end of the transition period on 31 December 2020 (letter here).

Action

Contractors are advised to:

  • Note the content of the letter and advise their dispensary teams accordingly.

Colleagues in CPNI will continue to update you on these matters as EU Exit progresses.

Yours sincerely

Mike

Sent on behalf of Prof Mike Mawhinney | Head of Regulatory Affairs

Dear Contractor

You will be aware that import declarations will be required for goods moving from Great Britain (GB) to Northern Ireland (NI) from 1 January 2021. These include medicines, medical devices and medical consumables.
 
In relation to registering with the Trader Support Service (TSS) and obtaining an XI EORI, the CPO has written to contractors providing details of a webinar dedicated to the healthcare sector in respect of these matters (letter here).

Action

Contractors are advised to note:

Colleagues in CPNI will continue to support you during the EU Exit process.

Yours sincerely

Mike

Sent on behalf of Prof Mike Mawhinney | Head of Regulatory Affairs

Dear Colleague

Please see correspondence here for your attention, from Dr Michael McBride, Chief Medical Officer and Cathy Harrison, Chief Pharmaceutical Officer.

Yours sincerely

SENT ON BEHALF OF GERARD GREENE | Chief Executive

FOR THE ATTENTION OF CONTRACTORS PROVIDING FLU VACCINATION SERVICE FOR HEALTH & SOCIAL CARE WORKERS

Please find correspondence here for your attention, from Kathryn Turner, Pharmacy Lead, HSCB.

Yours sincerely

Vanessa

SENT FOR AND BEHALF OF DR. VANESSA CHAMBERS | Head of Policy & Development